GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fees and other income is the income earned by insurance companies other than providing insurances. Synageva BioPharma Corp's fees and other income for the three months ended in Dec. 2013 was $3.47 Mil. Its fees and other income for the trailing twelve months (TTM) ended in Dec. 2013 was $13.37 Mil.
Synageva BioPharma Corp's quarterly fees and other income declined from Jun. 2013 ($3.41 Mil) to Sep. 2013 ($1.37 Mil) but then increased from Sep. 2013 ($1.37 Mil) to Dec. 2013 ($3.47 Mil).
Synageva BioPharma Corp's annual fees and other income increased from Dec. 2011 ($2.10 Mil) to Dec. 2012 ($14.95 Mil) but then declined from Dec. 2012 ($14.95 Mil) to Dec. 2013 ($13.37 Mil).
Income earned by insurance companies other than providing insurances. It includes investing income, fees and interest income.
Synageva BioPharma Corp Fees and Other Income for the trailing twelve months (TTM) ended in Dec. 2013 was 5.118 (Mar. 2013 ) + 3.413 (Jun. 2013 ) + 1.369 (Sep. 2013 ) + 3.474 (Dec. 2013 ) = $13.37 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data